The University of Maryland Institute for Genome Sciences and OpGen,Incorporated are to collaborate on a microbial database.To the untrained eye,OpGen's maps of genomic sequences look like colorful bar codes.To scientists,however,the maps enable rapid,accurate assembly and analysis of DNA sequence data of the whole genome.The OpGen maps advance the understanding of clinically relevant disease microorganisms.
OpGen and the University of Maryland Institute for Genomic Sciences have announced their collaboration in developing a database of high quality,finished and annotated microbial sequences.IGS will provide clinically characterized microbial samples and sequencing data,especially from the National Institutes of Health microbial genomic studies.OpGen will contribute the optical maps and sequence finishing technology.
This database will serve as an extraordinary set of reference organism templates to be used by the large number of resequencing efforts worldwide,said IGS director Claire Fraser-Liggett,PhD,who is also a professor at the University of Maryland School of Medicine.Such databases inform microbiology research and clinical diagnostics,providing insight into microbial genome architecture in a more complete and accurate way.
iShares Nasdaq Biotechnology Index Fund(IBB)
Showing posts with label Institute for Genomic Sciences. Show all posts
Showing posts with label Institute for Genomic Sciences. Show all posts
Friday, May 27, 2011
Thursday, March 3, 2011
Letter to My Readers
Dear Readers,
Please note that this Friday's post will be published in the International Daybook blog,available in the link list in the left column.It deals with a distinguished researcher at the University of Maryland Baltimore,Dr.Claire M. Fraser-Liggett,one of America's leading women in science,and the new Institute for Genomic Sciences she heads,which is of global stature.
On a personal level,it is possible I will be on medical leave for at least part of the month of April.In that case,the posts may be fewer or absent entirely.I am dealing with heart valve disease.
If I am away for awhile next month,it would be a good time for readers to go back into the archives and catch up on their reading.As well,a number of current articles by other journalists will be available in the left hand column.You can still get plenty of information here and I will keep you informed about my status as best I can.
I really appreciate all of your interest in these important topics.
Sincerely,
Andrew Taylor
P.S. For those who are interested in biotech,the exchange-traded fund listed below has long been a favorite.It covers 126 holdings.
iShares Nasdaq Biotechnology Index Fund(IBB)
Please note that this Friday's post will be published in the International Daybook blog,available in the link list in the left column.It deals with a distinguished researcher at the University of Maryland Baltimore,Dr.Claire M. Fraser-Liggett,one of America's leading women in science,and the new Institute for Genomic Sciences she heads,which is of global stature.
On a personal level,it is possible I will be on medical leave for at least part of the month of April.In that case,the posts may be fewer or absent entirely.I am dealing with heart valve disease.
If I am away for awhile next month,it would be a good time for readers to go back into the archives and catch up on their reading.As well,a number of current articles by other journalists will be available in the left hand column.You can still get plenty of information here and I will keep you informed about my status as best I can.
I really appreciate all of your interest in these important topics.
Sincerely,
Andrew Taylor
P.S. For those who are interested in biotech,the exchange-traded fund listed below has long been a favorite.It covers 126 holdings.
iShares Nasdaq Biotechnology Index Fund(IBB)
Subscribe to:
Posts (Atom)